156 related articles for article (PubMed ID: 9247603)
1. Evidence that expression of a mutated p53 gene attenuates apoptotic cell death in human gastric intestinal-type carcinomas in vivo.
Ishida M; Gomyo Y; Ohfuji S; Ikeda M; Kawasaki H; Ito H
Jpn J Cancer Res; 1997 May; 88(5):468-75. PubMed ID: 9247603
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis, cell proliferation and expression of oncogenes in gastric carcinomas induced by preoperative administration of 5-fluorouracil.
Kimura H; Konishi K; Kaji M; Maeda K; Yabushita K; Tsuji M; Ogino H; Satomura Y; Unoura M; Miwa A
Oncol Rep; 2000; 7(5):971-6. PubMed ID: 10948324
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling.
Kasagi N; Gomyo Y; Shirai H; Tsujitani S; Ito H
Jpn J Cancer Res; 1994 Sep; 85(9):939-45. PubMed ID: 7961123
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis in human gastric mucosa, chronic gastritis, dysplasia and carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling.
Ishida M; Gomyo Y; Tatebe S; Ohfuji S; Ito H
Virchows Arch; 1996 Jul; 428(4-5):229-35. PubMed ID: 8764931
[TBL] [Abstract][Full Text] [Related]
5. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP.
Gomyo Y; Osaki M; Kaibara N; Ito H
Int J Cancer; 1996 May; 66(5):594-9. PubMed ID: 8647618
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of MDM2 in prostate carcinoma.
Leite KR; Franco MF; Srougi M; Nesrallah LJ; Nesrallah A; Bevilacqua RG; Darini E; Carvalho CM; Meirelles MI; Santana I; Camara-Lopes LH
Mod Pathol; 2001 May; 14(5):428-36. PubMed ID: 11353053
[TBL] [Abstract][Full Text] [Related]
7. Frequent occurrence of apoptosis is an early event in the oncogenesis of human gastric carcinoma.
Ikeda M; Shomori K; Endo K; Makino T; Matsuura T; Ito H
Virchows Arch; 1998 Jan; 432(1):43-7. PubMed ID: 9463586
[TBL] [Abstract][Full Text] [Related]
8. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia.
Ochiai A; Yamauchi Y; Hirohashi S
Int J Cancer; 1996 Feb; 69(1):28-33. PubMed ID: 8600055
[TBL] [Abstract][Full Text] [Related]
9. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
10. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
11. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
[TBL] [Abstract][Full Text] [Related]
12. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis.
Cho JH; Kim WH
Pathol Res Pract; 1998; 194(5):309-17. PubMed ID: 9651943
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic cell death and its relationship to gastric carcinogenesis.
Bir F; Calli-Demirkan N; Tufan AC; Akbulut M; Satiroglu-Tufan NL
World J Gastroenterol; 2007 Jun; 13(23):3183-8. PubMed ID: 17589896
[TBL] [Abstract][Full Text] [Related]
14. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis.
Shiina H; Igawa M; Shigeno K; Yamasaki Y; Urakami S; Yoneda T; Wada Y; Honda S; Nagasaki M
Oncology; 1999 Apr; 56(3):239-47. PubMed ID: 10202280
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of p53 in gastric carcinoma.
Fukunaga M; Monden T; Nakanishi H; Ohue M; Fukuda K; Tomita N; Shimano T; Mori T
Am J Clin Pathol; 1994 Feb; 101(2):177-80. PubMed ID: 8116572
[TBL] [Abstract][Full Text] [Related]
17. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype.
Shibata N; Watari J; Fujiya M; Tanno S; Saitoh Y; Kohgo Y
Hum Pathol; 2003 Jan; 34(1):32-40. PubMed ID: 12605364
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis.
Hoshi T; Sasano H; Kato K; Yabuki N; Ohara S; Konno R; Asaki S; Toyota T; Tateno H; Nagura H
Anticancer Res; 1998; 18(6A):4347-53. PubMed ID: 9891491
[TBL] [Abstract][Full Text] [Related]
19. Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer.
Jiang PH; Motoo Y; Garcia S; Iovanna JL; Pébusque MJ; Sawabu N
World J Gastroenterol; 2006 Feb; 12(5):691-6. PubMed ID: 16521180
[TBL] [Abstract][Full Text] [Related]
20. Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma.
Sato S; Kigawa J; Minagawa Y; Okada M; Shimada M; Takahashi M; Kamazawa S; Terakawa N
Cancer; 1999 Oct; 86(7):1307-13. PubMed ID: 10506718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
